Bosentan Therapy in Patients With Eisenmenger Syndrome

Abstract

In this first placebo-controlled trial in patients with Eisenmenger syndrome, bosentan was well tolerated and improved exercise capacity and hemodynamics without compromising peripheral oxygen saturation.